Literature DB >> 28978260

Presentation of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma in a Warthin Tumor: Case Report and Literature Review.

Hadeel Jawad1, Peter McCarthy1, Gerard O'Leary2, Cynthia C Heffron1.   

Abstract

Warthin tumor is the second most common salivary gland neoplasm. It occurs more commonly in males than in females. Malignant transformation in Warthin tumor is a rare but well-recognized phenomenon; however, the development or presentation of lymphoma in a Warthin tumor is rare. An 80-year-old man presented with painless mass of the right parotid gland of 2 years duration with recent ulceration of the overlying skin and right cervical lymphadenopathy underwent a surgical resection of parotid mass and biopsy of the periglandular lymph nodes. The histological diagnosis was malignant lymphoma, chronic lymphocytic leukemia/small lymphocytic lymphoma, present within the stroma of a Warthin tumor, and also present within the adjacent lymph node. This case is the third reported case describing a collision of Warthin tumor and chronic lymphocytic leukemia/small lymphocytic lymphoma. It also emphasizes the importance of careful examination of the lymphoid stroma of these tumors.

Entities:  

Keywords:  Warthin tumor; chronic lymphocytic leukemia/small lymphocytic lymphoma; parotid gland

Mesh:

Year:  2017        PMID: 28978260     DOI: 10.1177/1066896917734371

Source DB:  PubMed          Journal:  Int J Surg Pathol        ISSN: 1066-8969            Impact factor:   1.271


  2 in total

1.  Prevalence of Lymphoid Neoplasia in a Retrospective Analysis of Warthin Tumor: A Single Institution Experience.

Authors:  F N U Alnoor; Jatin S Gandhi; Matthew K Stein; Jorge Solares; Joel F Gradowski
Journal:  Head Neck Pathol       Date:  2020-04-23

2.  Diffuse large B-cell lymphoma arising from follicular lymphoma with warthin's tumor of the parotid gland - immunophenotypic and genetic features: A case report.

Authors:  Chang-Song Wang; Xia Chu; Di Yang; Lei Ren; Nian-Long Meng; Xue-Xia Lv; Tian Yun; Yan-Sha Cao
Journal:  World J Clin Cases       Date:  2019-11-26       Impact factor: 1.337

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.